BPI France launches InnoBio 2
BPI France, alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen and Servier, have launched InnoBio 2, setting a target of €200-250m and aiming for a first close in September.
More on Funds
Inovia holds close on $600m for double fundraise, launches in London
Initially launched the funds in May 2018 and held initial closes towards the end of the year
Hi Inov holds first close for Hi Inov 2 on €90m
Series-A specialist also partners with Axeleo Capital for expansion into seed transactions
Siparex Investimenti 3 to be launched in 2019
Fund is managed by Insec Equity Partners, which is based in Milan and led by Barbini and Gianola
Gain Capital holds €28.4m first close for third fund-of-funds
Vehicle has a target of €60m and will look to hold a final close by the end of 2019
Latest News
Essling backs Evolucare Group
GP invests in the software company via Essling Expansion, a fund that recently held a first close
Naxicap-backed BVA bolts on Doxa
BVA expects to become one of the main market research groups in Europe and reach revenues of €200m
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Augmentum leads £150m debt and equity round for Iwoca
NIBC and existing investors including Prime also took part in the round for the SME lender